Literature DB >> 16765717

Reversible posterior leukoencephalopathy in patients with systemic lupus erythematosus.

Molly D Magnano1, Thomas M Bush, Ivonne Herrera, Roy D Altman.   

Abstract

BACKGROUND: The development of central nervous system (CNS) symptoms in patients with preexisting systemic lupus erythematosus (SLE) evokes a wide differential diagnosis. Reversible posterior leukoencephalopathy (RPLE) is a rapidly evolving neurologic syndrome with characteristic clinical and radiographic features. Conditions commonly associated with RPLE include hypertensive encephalopathy, eclampsia, immunosuppressive drugs, and inflammatory disorders.
OBJECTIVES: To describe our experience with RPLE in patients with concomitant SLE and review the literature.
METHODS: The details of 5 novel cases and a MEDLINE review of the literature concerning the development of RPLE in association with SLE are presented.
RESULTS: All cases included patients with SLE who developed the acute onset of headache, altered mental status, visual changes, and seizures. Neuroimaging demonstrated posterior white matter edema involving the parietal, temporal, and occipital lobes. Complete clinical and radiographic recovery occurred with prompt antihypertensive treatment and supportive care. Literature review identified 16 additional cases of RPLE occurring in patients with active SLE; the majority of these reports was similar in presentation and outcome to our experience.
CONCLUSIONS: It is likely that the clinical manifestations and neuroimages in these lupus patients were the result of the RPLE syndrome. Fortunately, this cause of "secondary" CNS symptoms in patients with SLE is readily reversible when diagnosed early and treated with blood pressure control and supportive care.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16765717     DOI: 10.1016/j.semarthrit.2006.01.002

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  10 in total

Review 1.  Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

Review 2.  Reversible posterior leukoencephalopathy syndrome in cancer.

Authors:  Christopher Vaughn; Louann Zhang; David Schiff
Journal:  Curr Oncol Rep       Date:  2008-01       Impact factor: 5.075

3.  Acute epiglottitis as the initial presentation of pediatric Systemic Lupus Erythematosus.

Authors:  Sirirat Charuvanij; Kristin M Houghton
Journal:  Pediatr Rheumatol Online J       Date:  2009-10-31       Impact factor: 3.054

4.  Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome.

Authors:  Neal S Parikh; Andrew D Schweitzer; Robert J Young; Ashley E Giambrone; John Lyo; Sasan Karimi; Anna Knobel; Ajay Gupta; Babak B Navi
Journal:  J Neurol Sci       Date:  2017-06-29       Impact factor: 3.181

5.  MR imaging findings suggestive of posterior reversible encephalopathy syndrome in adolescents with systemic lupus erythematosus.

Authors:  Eyal Muscal; Elfrides Traipe; Marietta M de Guzman; Barry L Myones; Robin L Brey; Jill V Hunter
Journal:  Pediatr Radiol       Date:  2010-01-30

Review 6.  The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients.

Authors:  Tatjana Zekić; Mirjana Stanić Benić; Ronald Antulov; Igor Antončić; Srđan Novak
Journal:  Rheumatol Int       Date:  2017-10-17       Impact factor: 2.631

7.  Acute Kidney Injury, Recurrent Seizures, and Thrombocytopenia in a Young Patient with Lupus Nephritis: A Diagnostic Dilemma.

Authors:  Hector Alvarado Verduzco; Anjali Acharya
Journal:  Case Rep Nephrol       Date:  2016-12-04

8.  Bilateral Visual Loss as Presenting Symptom of Posterior Reversible Encephalopathy Syndrome in a Patient with HIV/Tuberculosis Coinfection: A Case Report.

Authors:  S Guerriero; L Ciracì; T Centoducati; F Pignatelli; V Lamargese; A Salvati; F Dicuonzo
Journal:  Case Rep Ophthalmol Med       Date:  2012-12-03

9.  Posterior reversible encephalopathy syndrome could be an underestimated variant of "reversible neurological deficits" in Systemic Lupus Erythematosus.

Authors:  Bin Liu; Xuan Zhang; Feng-Chun Zhang; Yuan Yao; Ri-Zhi Zhou; Miao-Miao Xin; Li-Qin Wang
Journal:  BMC Neurol       Date:  2012-12-05       Impact factor: 2.474

10.  Clinical features, outcome, and associated factors for posterior reversible encephalopathy in Thai patients with systemic lupus erythematosus: a case-control study.

Authors:  Usanee Damrongpipatkul; Kanokporn Oranratanachai; Nuntana Kasitanon; Salita Wuttiplakorn; Worawit Louthrenoo
Journal:  Clin Rheumatol       Date:  2017-11-04       Impact factor: 3.650

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.